Clinical characteristics between survivors and nonsurvivors of COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support: a systematic …
Background: The use of extracorporeal membrane oxygenation (ECMO) in coronavirus
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
Clinical Characteristics Between Survivors and Nonsurvivors of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Support: A Systematic …
WH Chong, BK Saha, BI Medarov - Journal of Intensive Care …, 2021 - europepmc.org
Background: The use of extracorporeal membrane oxygenation (ECMO) in coronavirus
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
Clinical Characteristics Between Survivors and Nonsurvivors of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Support: A Systematic …
WH Chong, BK Saha… - Journal of Intensive Care …, 2022 - search.ebscohost.com
Background: The use of extracorporeal membrane oxygenation (ECMO) in coronavirus
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
Clinical Characteristics Between Survivors and Nonsurvivors of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Support: A Systematic …
WH Chong, BK Saha… - Journal of intensive …, 2022 - pubmed.ncbi.nlm.nih.gov
Background: The use of extracorporeal membrane oxygenation (ECMO) in coronavirus
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …
disease 2019 (COVID-19) for refractory respiratory failure, severe cardiac dysfunction, and …